Subclinical Hyperthyroidism: Diagnostic Criteria and Treatment Guidelines Review of the 2015 European Thyroid Association Guidelines «Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism»

Main Article Content

V.V. Galitskaya

Abstract

The article discusses European Thyroid Association guidelines on the diagnosis and treatment of subclinical hyperthyroidism.

Article Details

How to Cite
Galitskaya, V. “Subclinical Hyperthyroidism: Diagnostic Criteria and Treatment Guidelines Review of the 2015 European Thyroid Association Guidelines «Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism»”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), no. 6.78, Nov. 2016, pp. 61-65, doi:10.22141/2224-0721.6.78.2016.81859.
Section
Clinical Thyroidology

References

Biondi В., Bartalena L., Cooper D.S. et al. The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism // Eur. Thyroid J. — 2015. — 4. — 149-163; DOI: 10.1159/000438750.

Surks M.I., Ortiz E., Daniels G.H. et al: Subclinical thyroid disease: scientific review and guidelinesfor diagnosis and management // JAMA. — 2004. — 291. — 228-238.

Biondi B., Palmieri E.A., Klain M., Schlumberger M., Filetti S., Lombardi G. Subclinical hyperthyroidism: clinical features and treatment options // Eur. J. Endocrinol. — 2005. — 152. — 1-9.

Biondi B., Cooper D.S. The clinical significance of subclinical thyroid dysfunction // Endocr. Rev. — 2008. — 29. — 76-131.

Bahn R.S., Burch H.B., Cooper D.S. et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists // Thyroid. — 2011. — 21. — 593-646.

Cooper D.S., Biondi B. Subclinical thyroid disease // Lancet. — 2012. — 379. — 1142-1154.

Mitchell A.L., Pearce S.H. How should we treat patients with low serum thyrotropin concentrations? // Clin. Endocrinol. — 2010. — 72. — 292-296.

Bülow Pedersen I., Knudsen N., Jørgensen T., Perrild H., Ovesen L., Laurberg P. Large differences in incidences of overt hyper- and hypothyroidism associated with a small difference in iodine intake: a prospective comparative register-based population survey // J. Clin. Endocrinol. Metab. — 2002. — 87. — 4462-4469.

Marqusee E., Haden S.T., Utiger R.D. Subclinical thyrotoxicosis // Endocrinol. Metab. Clin. North Am. — 1998. — 27. — 37-49.

Canaris G.J., Manowitz N.R., Mayor G., Ridgway E.C. The Colorado thyroid disease prevalence study // Arch Intern. Med. — 2000. — 160. — 526-534.

Hollowell J.G., Staehling N.W., Flanders W.D. et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988-1994): National Health and Nutrition Examination Survey (NHANES III) // J. Clin. Endocrinol. Metab. — 2002. — 87. — 489-499.

Aghini-Lombardi F., Antonangeli L., Martino E. et al. The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey // J. Clin. Endocrinol. Metab. — 1999. — 84. — 561-566.

Paschke R., Hegedüs L., Alexander E., Valcavi R., Papini E., Gharib H. Thyroid nodule guidelines: agreement, disagreement and need for future research // Nat. Rev. Endocrinol. — 2011. — 7. — 354-361.

Baloch Z., Carayon P., Conte-Devolx B., Demers L.M., Feldt-Rasmussen U., Henry J.F., LiVosli V.A., Niccoli-Sire P., John R., Ruf J., Smyth P.P., Spencer C.A., Stockigt J.R. Guidelines Committee, National Academy of Clinical Biochemistry: Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease // Thyroid. — 2003. — 13. — 3-126.

Figge J., Leinung M., Goodman A.D., Izquierdo R., Mydosh T., Gates S., Line B., Lee D.W. The clinical evaluation of patients with subclinical hyperthyroidism and free triiodothyronine (free T 3) toxicosis // Am. J. Med. — 1994. — 96. — 229-234.

Cooper D.S., Laurberg P. Hyperthyroidism in pregnancy // Lancet Diabetes Endocrinol. — 2013. — 1. — 238-249.

Harman S.M., Wehmann R.E., Blackman M.R. Pituitary-thyroid hormone economy in healthy aging men: basal indices of thyroid function and thyrotropin responses to constant infusions of thyrotropin releasing hormone // J. Clin Endocrinol. Metab. — 1984. — 58. — 320-326.

Mariotti S., Franceschi C., Cossarizza A., Pinchera A. The aging thyroid // Endocr. Rev. — 1995. — 16. — 686-715.

Surks M.I., Boucai L. Age- and race-based serum thyrotropin reference limits // J. Clin. Endocrinol. Metab. — 2010. — 95. — 496-502.

Magri F., Muzzoni B., Cravello L., Fioravanti M., Busconi L., Camozzi D., Vignati G., Ferrari E. Thyroid function in physiological aging and in centenarians: possible relationships with some nutritional markers // Metabolism. — 2002. — 51. — 105-109.

Mariotti S., Barbesino G., Caturegli P., Bartalena L., Sansoni P., Fagnoni F., Monti D., Fagiolo U., Franceschi C., Pinche­ra A. Complex alteration of thyroid function in healthy centenarians // J. Clin. Endocrinol. Metab. — 1993. — 77. — 1130-1134.

Belin R.M., Astor B.C., Powe N.R., Ladenson P.W. Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in the Third National Health and Nutrition Examination Survey (NHANES III) // J. Clin. Endocrinol. Metab. — 2004. — 89. — 6077-6086.

Diana T., Kanitz M., Lehmann M., Li Y., Olivo P.D., Kahaly G.J. Standardization of a bioassay for thyrotropin receptor stimulating auto antibodies // Thyroid. — 2015. — 25. — 169-175.

Pedersen I.B., Knudsen N., Perrild H., Ovesen L., Laurberg P. TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves’ disease and multinodular toxic goitre: a comparison of two competitive binding assays // Clin. Endocrinol. — 2001. — 55. — 381-390.